![Timothy D. Ocain](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Timothy D. Ocain
Nessuna posizione attualmente
Provenienza dei contatti di primo grado di Timothy D. Ocain
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Millennium Pharmaceuticals, Inc.
![]() Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA.
102
| Subsidiary | Pharmaceuticals: Major | 102 |
Seaside Therapeutics LLC
![]() Seaside Therapeutics LLC Medical DistributorsDistribution Services Seaside Therapeutics LLC engages in the development of drug treatments to correct or improve the course of autism, fragile X syndrome and other neurodevelopmental disorders. Its products include STX209, STX107, and STX110. The company was founded by Randall L. Carpenter and Mark F. Bear in 2005 and is headquartered in Cambridge, MA.
1
| Private Company | Medical Distributors | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Timothy D. Ocain tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | President Director/Board Member General Counsel Director/Board Member Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
MOMENTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Operating Officer Director/Board Member Corporate Officer/Principal General Counsel Corporate Officer/Principal General Counsel Founder Corporate Officer/Principal | |
Massachusetts Institute of Technology | College/University | Doctorate Degree Masters Business Admin Doctorate Degree Doctorate Degree Doctorate Degree Undergraduate Degree Doctorate Degree | |
Third Rock Ventures LLC
![]() Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor Consultant / Advisor Founder Private Equity Investor Private Equity Investor Private Equity Investor | |
Biotechnology Innovation Organization
![]() Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Corporate Secretary Founder Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
LeukoSite, Inc.
![]() LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology LeukoSite, Inc. develops drugs for treatment of cancer and inflammatory diseases. It produces drugs to block autoimmune and viral diseases associated with malfunctioning leukocytes or white blood cells. The company was founded in 1992 and is located in Cambridge, MA. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
BIOGEN INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Northeastern University
![]() Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Undergraduate Degree Graduate Degree | |
Warp Drive Bio, Inc.
![]() Warp Drive Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Warp Drive Bio, Inc. focused on proprietary genomic technology to discover drugs of natural origin. The firm deployed proprietary platforms Genome Mining and Small Molecule Assisted Receptor Targeting (SMART) to discover and develop novel molecules addressing new pharmacologic mechanisms. The company was founded by Gregory L. Verdine, George McDonald Church, and James A. Wells in 2012 and was headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director of Finance/CFO Chief Executive Officer | |
University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree Doctorate Degree Undergraduate Degree | |
BLUEPRINT MEDICINES CORPORATION | Biotechnology | Chairman Director of Finance/CFO Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Genetics Institute LLC
![]() Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal | |
AVEO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Founder Investor Relations Contact | |
Rutgers State University of New Jersey | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree Corporate Officer/Principal | |
University of Massachusetts | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
DECIBEL THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Chief Executive Officer Director/Board Member Chief Executive Officer | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
VISTERRA INC | Pharmaceuticals: Major | President Director/Board Member Founder General Counsel | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
KARYOPHARM THERAPEUTICS INC. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Director/Board Member Founder | |
REGENERON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
BLUEBIRD BIO, INC. | Biotechnology | Director/Board Member Director/Board Member Chief Operating Officer Chief Operating Officer | |
PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Founder Chief Executive Officer | |
FORMA THERAPEUTICS HOLDINGS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Human Resources Officer Director of Finance/CFO | |
MPM BioImpact, Inc
![]() MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Chief Executive Officer Private Equity Investor Private Equity Investor Private Equity Investor | |
AGIOS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Executive Officer Chairman Director/Board Member | |
Biogen MA, Inc.
![]() Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Biotechnology | Director of Finance/CFO Director of Finance/CFO Comptroller/Controller/Auditor Corporate Officer/Principal | |
SYROS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer | |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
Tufts University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
DuPont Merck Pharmaceutical Co.
![]() DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Sales & Marketing Corporate Officer/Principal | |
Metamark Genetics, Inc.
![]() Metamark Genetics, Inc. Medical/Nursing ServicesHealth Services Metamark Genetics, Inc. provides molecular diagnostics services. It develops prognostic and predictive diagnostic tests that will enable personalized treatment planning for cancer patients. It transforms cancer diagnosis and treatment by developing pioneering diagnostic products based on its prognosis determinants platform. The company was founded by Kenneth E. Weg, Raju S. Kucherlapati, David Rimm, Lynda Chin and Ronald A. DePinho in November 2007 and is headquartered in Waltham, MA. | Medical/Nursing Services | Founder Director/Board Member Director/Board Member | |
Allergan GI Corp.
![]() Allergan GI Corp. BiotechnologyHealth Technology Allergan GI Corp. develops peptide therapeutics for the treatment of gastrointestinal disorders. It provides RM-493 a small-peptide melanocortin-4 receptor agonist, for the treatment of obesity and diabetes, and RM-131 a small-peptide ghrelin agonist, for the treatment of diabetic gastro paresis and other gastrointestinal functional disorders. The company was founded by Bart Henderson and Elizabeth Stoner in 2008 and is headquartered in Madison, NJ. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
SAGE THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO Chairman | |
CONSTELLATION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | President Director/Board Member Director/Board Member | |
VOYAGER THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Director of Finance/CFO General Counsel | |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Washington University in St. Louis | College/University | Graduate Degree Undergraduate Degree Doctorate Degree | |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
CURIS, INC. | Biotechnology | General Counsel Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Stanford University | College/University | Corporate Officer/Principal Doctorate Degree Graduate Degree | |
Princeton University | College/University | Undergraduate Degree Corporate Officer/Principal Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 49 |
Francia | 2 |
Giappone | 2 |
Settori
Health Technology | 33 |
Consumer Services | 11 |
Finance | 4 |
Commercial Services | 4 |
Miscellaneous | 2 |
Posizioni
Director/Board Member | 442 |
Corporate Officer/Principal | 330 |
Independent Dir/Board Member | 128 |
Undergraduate Degree | 93 |
Chief Tech/Sci/R&D Officer | 92 |
Contatti più connessi
Insiders | |
---|---|
James Topper | 52 |
John Maraganore | 38 |
Nicholas G. Galakatos | 38 |
Neil Exter | 33 |
Norman Selby | 32 |
Alan Crane | 29 |
Charles Homcy | 29 |
Chris Mirabelli | 29 |
Steven Holtzman | 28 |
Vaughn M. Kailian | 27 |
Mark Levin | 26 |
Michael Kauffman | 24 |
Julian Adams | 23 |
Kimberlee Drapkin | 23 |
Deborah Dunsire | 20 |
- Borsa valori
- Insiders
- Timothy D. Ocain
- Connessioni Società